Effects of the selective GPER1 agonist G1 on bone growth

Estrogens may affect bone growth locally or systemically via the known estrogen receptors ESR1, ESR2 and G protein-coupled estrogen receptor 1 (GPER1). Mouse and human growth plate chondrocytes have been demonstrated to express GPER1 and ablation of this receptor increased bone length in mice. Therefore, GPER1 is an attractive target for therapeutic modulation of bone growth, which has never been explored. To investigate the effects of activated GPER1 on the growth plate, we locally exposed mouse metatarsal bones to different concentrations of the selective GPER1 agonist G1 for 14 days ex vivo. The results showed that none of the concentrations of G1 had any direct effect on metatarsal bone growth when compared to control. To evaluate if GPER1 stimulation may systemically modulate bone growth, ovariectomized C57BL/6 mice were treated with G1 or β-estradiol (E2). Similarly, G1 did not influence tibia and femur growth in treated mice. As expected, E2 treatment suppressed bone growth in vivo. We conclude that ligand stimulation of GPER1 does not influence bone growth in mice.

[1]  Lei Guo,et al.  17β-Estradiol on the Expression of G-Protein Coupled Estrogen Receptor (GPER/GPR30) Mitophagy, and the PI3K/Akt Signaling Pathway in ATDC5 Chondrocytes In Vitro , 2018, Medical science monitor : international medical journal of experimental and clinical research.

[2]  A. M. Etgen,et al.  Lordosis facilitated by GPER-1 receptor activation involves GnRH-1, progestin and estrogen receptors in estrogen-primed rats , 2018, Hormones and Behavior.

[3]  Daniel A. Gorelick,et al.  Crosstalk between nuclear and G protein-coupled estrogen receptors. , 2017, General and comparative endocrinology.

[4]  M. Lagerquist,et al.  Regulation of bone growth via ligand-specific activation of estrogen receptor alpha. , 2015, The Journal of endocrinology.

[5]  F. Beretti,et al.  Estrogen receptor signaling in the ferutinin-induced osteoblastic differentiation of human amniotic fluid stem cells. , 2016, Life sciences.

[6]  B. Boyan,et al.  Rapid steroid hormone actions via membrane receptors. , 2016, Biochimica et biophysica acta.

[7]  M. Barton.  Not lost in translation: Emerging clinical importance of the G protein-coupled estrogen receptor GPER , 2016, Steroids.

[8]  T. Sabo-Attwood,et al.  The G Protein-Coupled Estrogen Receptor Agonist G-1 Inhibits Nuclear Estrogen Receptor Activity and Stimulates Novel Phosphoproteomic Signatures. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[9]  Yan Yan,et al.  Role of GPER on proliferation, migration and invasion in ligand‐independent manner in human ovarian cancer cell line SKOV3 , 2015, Cell biochemistry and function.

[10]  M. Lagerquist,et al.  The role of estrogen receptor α in the regulation of bone and growth plate cartilage , 2013, Cellular and Molecular Life Sciences.

[11]  D. Soulet,et al.  Implication of GPER1 in neuroprotection in a mouse model of Parkinson's disease , 2013, Neurobiology of Aging.

[12]  P. Thomas,et al.  Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology. , 2012, Endocrinology.

[13]  J. Zerwekh,et al.  GPR30 Deficiency Causes Increased Bone Mass, Mineralization, and Growth Plate Proliferative Activity in Male Mice , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  L. Dai,et al.  Gender- and region-specific variations of estrogen receptor α and β expression in the growth plate of spine and limb during development and adulthood , 2011, Histochemistry and Cell Biology.

[15]  S. Grässel,et al.  Estradiol inhibits chondrogenic differentiation of mesenchymal stem cells via nonclassic signaling. , 2010, Arthritis and rheumatism.

[16]  M. Lagerquist,et al.  Amelioration of collagen-induced arthritis and immune-associated bone loss through signaling via estrogen receptor alpha, and not estrogen receptor beta or G protein-coupled receptor 30. , 2010, Arthritis and rheumatism.

[17]  Y. Mizukami.  In vivo functions of GPR30/GPER-1, a membrane receptor for estrogen: from discovery to functions in vivo. , 2010, Endocrine journal.

[18]  A. Chagin,et al.  Catch-up growth after dexamethasone withdrawal occurs in cultured postnatal rat metatarsal bones. , 2010, The Journal of endocrinology.

[19]  E. Prossnitz,et al.  Mechanisms of estrogen signaling and gene expression via GPR30 , 2009, Molecular and Cellular Endocrinology.

[20]  A. M. Etgen,et al.  GPR30 Differentially Regulates Short Latency Responses of Luteinising Hormone and Prolactin Secretion to Oestradiol , 2009, Journal of neuroendocrinology.

[21]  B. Olde,et al.  The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice. , 2009, American journal of physiology. Endocrinology and metabolism.

[22]  B. Olde,et al.  Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. , 2009, Endocrinology.

[23]  T. Heino,et al.  The novel estrogen receptor G-protein-coupled receptor 30 is expressed in human bone. , 2008, The Journal of endocrinology.

[24]  Tudor I. Oprea,et al.  GPR30: a novel therapeutic target in estrogen-related disease. , 2008, Trends in pharmacological sciences.

[25]  Tudor I. Oprea,et al.  Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. , 2008, Annual review of physiology.

[26]  A. Chagin,et al.  GPR30 estrogen receptor expression in the growth plate declines as puberty progresses. , 2007, The Journal of clinical endocrinology and metabolism.

[27]  S. Andò,et al.  The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. , 2006, Molecular endocrinology.

[28]  S. Andò,et al.  The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. , 2006, Molecular endocrinology.

[29]  Eric R. Prossnitz,et al.  A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling , 2005, Science.

[30]  S. Andò,et al.  The G Protein-coupled Receptor GPR30 Mediates c-fos Up-regulation by 17β-Estradiol and Phytoestrogens in Breast Cancer Cells* , 2004, Journal of Biological Chemistry.

[31]  E. Smeland,et al.  A novel putative G‐protein‐coupled receptor expressed in lung, heart and lymphoid tissue , 1997, FEBS letters.